SCHEMBL21497978

SCHEMBL21497978

CN1c2ccccc2Oc2ccc(C(F)(F)F)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 4/20 0.47
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
CYP1A2 P05177 3/20 0.41
CYP2D6 P10635 3/20 0.41
KIF11 P52732 1/20 0.41
SCN9A Q15858 3/20 0.39
TP53 P04637 4/20 0.39
RAB9A P51151 4/20 0.39
MAPK1 P28482 3/20 0.39
NPC1 O15118 2/20 0.39
ABCB1 P08183 2/20 0.39
HTR1A P08908 2/20 0.39
ADRA2A P08913 2/20 0.39
ADORA3 P0DMS8 2/20 0.39
CHRM1 P11229 2/20 0.39
TSHR P16473 2/20 0.39
DRD1 P21728 2/20 0.39
SLC6A2 P23975 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15492199 0.79 P2RX4 (0.40) ALDH1A1CYP1A2CYP2D6KIF11SCN9A
SCHEMBL23713626 0.79 KIF11 (0.47) ALDH1A1KDM4ECYP1A2CYP2D6KIF11
SCHEMBL47007 0.78 KDM4E (0.55) ALDH1A1KDM4ERAB9AMAPTSMN1; SMN2
SCHEMBL31067286 0.78 KDM4E (0.55) ALDH1A1KDM4ERAB9AMAPTSMN1; SMN2
SCHEMBL21497997 0.78 KDM4E (0.46) ALDH1A1KDM4ENR1H2NR1H3RAB9A
Hydrogen Sulfide SCHEMBL28845788 0.76 KDM4E (0.53) ALDH1A1KDM4ERAB9AMAPTSMN1; SMN2
SCHEMBL12841614 0.76 KDM4E (0.47) ALDH1A1KDM4ERAB9ALMNAMAPT
SCHEMBL15489933 0.76 P2RX4 (0.37) ALDH1A1CYP1A2CYP2D6KIF11SCN9A
SCHEMBL10133785 0.75 NR1H3 (0.48) ALDH1A1KDM4ENR1H2NR1H3KIF11
SCHEMBL13445191 0.75 KDM4E (0.46) ALDH1A1KDM4ERAB9ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450282-B2 Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2019-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450282-B2 Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols DDT, ODC1, CBR1 ALDH1A1 458/4885KDM4E 3221/4885NR1H2 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.